Hyperparathyroidism (PTH-mediated) vs Malignancy hypercalcemia (PTHrP)
How to tell Hyperparathyroidism (PTH-mediated) and Malignancy hypercalcemia (PTHrP) apart when a board question makes them look alike.
Step 2 CK pairs are in open beta while clinical review finishes. Spot an issue? Tell us.
Suppressed intact PTH in a hypercalcemic patient is the fastest discriminator for malignancy-driven hypercalcemia.
Side by side
Hypercalcemia with elevated or inappropriately normal intact PTH indicates PTH-mediated disease.
Marked hypercalcemia with suppressed intact PTH suggests non-PTH causes, commonly PTHrP-mediated malignancy.
Parathyroid-driven PTH excess increases bone resorption and renal calcium reabsorption.
Tumor-derived PTHrP activates PTH receptors, causing calcium elevation while endogenous PTH is suppressed.
Intact PTH is high or unsuppressed, calcium usually mildly to moderately elevated, phosphate often low, and 24-hour urine calcium is generally increased.
Corrected calcium is often above 13 to 14 mg/dL, intact PTH is suppressed below 20 pg/mL, PTHrP may be elevated, and 1,25-dihydroxy vitamin D is usually not elevated except in lymphoma.
The trap
The trap is assuming all high calcium with fatigue is primary hyperparathyroidism. The resolving clue is intact PTH suppression, which should trigger a malignancy-focused evaluation and urgent calcium-lowering therapy if severe.
The repair move
Next best step: begin isotonic saline resuscitation immediately, then add calcitonin 4 IU/kg subcutaneously every 12 hours for rapid temporary calcium reduction and give IV zoledronic acid 4 mg once for durable control. Simultaneously evaluate for malignancy source when PTH is suppressed.
Try a free question
CoreA patient with calcium 15.1 mg/dL is lethargic and dehydrated; intact PTH is 6 pg/mL. What is the next best step in management?
Show answer and explanation
Answer: A. Start IV normal saline then calcitonin and IV bisphosphonate. Symptomatic severe hypercalcemia requires immediate volume expansion and calcium-lowering therapy.
Why the other choices are tempting
- B. Outpatient localization studies delay emergency treatment.
- C. Thiazides increase calcium and worsen hypercalcemia.
- D. Calcium supplements are contraindicated in hypercalcemia.
- E. Observation risks arrhythmia, AKI, and neurologic decline.
Flashcards
Tap a card to flip it.
What intact PTH pattern points to PTH-mediated hypercalcemia?
An elevated or inappropriately normal intact PTH despite high calcium.
What intact PTH result suggests PTHrP-mediated malignancy hypercalcemia?
Suppressed intact PTH in the setting of marked hypercalcemia.
Quick answers
What is the fastest way to tell Hyperparathyroidism (PTH-mediated) from Malignancy hypercalcemia (PTHrP)?
Suppressed intact PTH in a hypercalcemic patient is the fastest discriminator for malignancy-driven hypercalcemia.
What is the key clue for Hyperparathyroidism (PTH-mediated)?
Hypercalcemia with elevated or inappropriately normal intact PTH indicates PTH-mediated disease.
What is the key clue for Malignancy hypercalcemia (PTHrP)?
Marked hypercalcemia with suppressed intact PTH suggests non-PTH causes, commonly PTHrP-mediated malignancy.
What is the common trap with Hyperparathyroidism (PTH-mediated) vs Malignancy hypercalcemia (PTHrP)?
The trap is assuming all high calcium with fatigue is primary hyperparathyroidism. The resolving clue is intact PTH suppression, which should trigger a malignancy-focused evaluation and urgent calcium-lowering therapy if severe.